Detalles de la búsqueda
1.
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Lancet;
403(10442): 2416-2425, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38763153
2.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Lancet;
403(10442): 2405-2415, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38763154
3.
Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials.
Lancet Oncol;
24(7): 783-797, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37414011
4.
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
Lancet;
399(10323): 447-460, 2022 01 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34953525
5.
Lack of transparent reporting of trial monitoring approaches in randomised controlled trials: A systematic review of contemporary protocol papers.
Clin Trials;
20(2): 121-132, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36629015
6.
Site staff perspectives on communicating trial results to participants: Cost and feasibility results from the Show RESPECT cluster randomised, factorial, mixed-methods trial.
Clin Trials;
20(6): 649-660, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37515519
7.
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.
PLoS Med;
19(6): e1003998, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35671327
8.
Practical guidance for planning resources required to support publicly-funded adaptive clinical trials.
BMC Med;
20(1): 254, 2022 08 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35945610
9.
Combining factorial and multi-arm multi-stage platform designs to evaluate multiple interventions efficiently.
Clin Trials;
19(4): 432-441, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35579066
10.
Testing approaches to sharing trial results with participants: The Show RESPECT cluster randomised, factorial, mixed methods trial.
PLoS Med;
18(10): e1003798, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34606495
11.
Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data.
Lancet;
396(10260): 1422-1431, 2020 10 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33002431
12.
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial.
Lancet;
396(10260): 1413-1421, 2020 10 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33002429
13.
Costs and staffing resource requirements for adaptive clinical trials: quantitative and qualitative results from the Costing Adaptive Trials project.
BMC Med;
19(1): 251, 2021 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34696781
14.
Monitoring strategies for clinical intervention studies.
Cochrane Database Syst Rev;
12: MR000051, 2021 12 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34878168
15.
The Lancet Commission on prostate cancer: planning for the surge in cases.
Lancet;
403(10437): 1683-1722, 2024 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38583453
16.
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
N Engl J Med;
377(4): 338-351, 2017 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28578639
17.
A third trial oversight committee: Functions, benefits and issues.
Clin Trials;
17(1): 106-112, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31665920
18.
Adding new experimental arms to randomised clinical trials: Impact on error rates.
Clin Trials;
17(3): 273-284, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32063029
19.
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.
Lancet;
392(10162): 2353-2366, 2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30355464
20.
Challenges of Using Routinely Collected Healthcare System Data in Randomised Trials.
Eur J Vasc Endovasc Surg;
2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38735523